PBM Legislation and the PBM-affiliated GPOs | AMCP 2024
Ross Margulies, J.D., M.P.H., a partner at the Foley Hoag law firm, discusses whether proposed transparency rules in the pharmacy benefit manager (PBM) legislation that Congress is considering might apply to the PBM-affiliated group purchasing organizations.
The pharmacy benefit manager (PBM) bills that Congress is currently considering include a variety of new transparency and reporting rules. Whether those rules would apply to the group purchasing organizations (GPOs) affiliated with the major PBMs is an open question
Ross Margulies, J.D., M.P.H., a partner at Foley Hoag, a law firm headquartered in Boston, discussed PBMs and the PBM legislation today at the 2024 annual meeting of the Academy of Managed Care Pharmacy (AMCP).
In an interview with Managed Healthcare Executive prior to the meeting, Margulies said that most of the bills under consideration have provisions aimed at "affiliated entities" that might include the group purchasing organizations (GPOs).
Margulies also noted that the term PBM is not currently defined in most statutes and that the some of the definitional language in the current bills “could reach affiliated, PBM-owned GPOs.”
340B Program Is Driving Up Costs and Needs Urgent Reform | AMCP Annual 2025
April 7th 2025At the 2025 AMCP annual meeting in Houston from March 31 to April 3, John M. O'Brien, Pharm.D., MPH, president and CEO of the National Pharmaceutical Council (NPC), shared concerns and potential reforms in a conversation with Managed Healthcare Executive.
Read More
Exploring the Wide World of GLP-1s | AMCP Annual 2025
April 3rd 2025Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their effects on various other conditions, such as sleep apnea, substance use disorder and Alzheimer’s disease, according to panelists participating in a keynote session of the Academy of Managed Care Pharmacy annual meeting today in Houston.
Read More
2024-2025 Pharmacy Trends Include Improved Drug Shortages, More Pharmacy Closures | AMCP Annual 2025
April 2nd 2025Scott Biggs and Douglas M. Long of IQVIA delivered a keynote on 2024-2025 healthcare and pharmaceutical trends, highlighting drug shortages, pharmacy closures, and the United States dependence on imported pharmaceuticals.
Read More
